A comparison of 18F-FDG PET/MR with PET/CT in pulmonary tuberculosis
Authors:
- Benjamin A. ThomasBTBenjamin A. Thomas
- James S. MoltonJMJames S. Molton
- Francesca LeekFLFrancesca Leek
- Yan PangYPYan Pang
- John J. TotmanJTJohn J. Totman
- Nicholas I. PatonNPNicholas I. Paton
- David W. TownsendDTDavid W. Townsend
- 1 November 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 38 (11) , 971-978
Abstract
PET/computed tomography (CT) has been shown to detect lesions in patients with pulmonary tuberculosis (PTB) and may be useful for assessing PTB disease in clinical research studies. However, radiation dose is of concern for clinical research in individuals with an underlying curable disease. This study aimed to determine whether PET/MR is equivalent to PET/CT in PTB. Ten patients with microbiologically confirmed PTB were recruited. Patients received 129.0±4.1 MBq of fluorine-18-fluorodeoxyglucose. Five of the 10 patients underwent a PET/MR scan, followed by PET/CT. The remaining five were first imaged on the PET/CT, followed by the PET/MRI. PET acquisition began at 66.7±14.4 min (mean±SD) after injection when performing PET/MR first (PET/CT: 117.2±5.6 min) and 92.4±7.6 min when patients were imaged on PET/MR second (PET/CT: 61.1±3.9 min). PET data were reconstructed iteratively with Ordinary-Poisson Ordered-Subset Expectation-Maximization and reconstruction parameters were matched across the two scanners. A visual lesion detection task and a standardized uptake value (SUV) analysis were carried out. The CT Hounsfield unit values of PTB lesions were also compared with MR-based attenuation correction mu-map tissue classes. A total of 108 PTB lesions were detected on PET/MR and 112 on PET/CT. SUV analysis was carried out on 50 of these lesions that were observed with both modalities. Mean standardized uptake value (SUVmean) and maximum standardized uptake value (SUVmax) were significantly lower on PET/MR (SUVmean: 2.6±1.4; SUVmax: 4.3±2.5) than PET/CT (SUVmean: 3.5±1.5; SUVmax: 5.3±2.4). PET/MR visual performance was shown to be comparable to PET/CT in terms of the number of PTB lesions detected. SUVs were significantly lower on PET/MR. Dixon-based attenuation correction underestimates the linear attenuation coefficient of PTB lesions, resulting in lower SUVs compared with PET/CT. However, the use of PET/MR to measure the response of lung lesions to assess response to treatment in research studies is unlikely to be affected by these differences in quantification.Keywords
This publication has 17 references indexed in Scilit:
- Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomographyNature Medicine, 2016
- Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureNature Medicine, 2016
- Comparative Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic PatientsJournal of Nuclear Medicine, 2016
- 18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 PatientsJournal of Nuclear Medicine, 2016
- Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known MalignanciesJournal of Nuclear Medicine, 2015
- Imaging in tuberculosisInternational Journal of Infectious Diseases, 2015
- Advances in imaging of tuberculosisCurrent Opinion in Pulmonary Medicine, 2014
- Detection Rate, Location, and Size of Pulmonary Nodules in Trimodality PET/CT-MRInvestigative Radiology, 2013
- Patterns of pulmonary tuberculosis on FDG-PET/CTEuropean Journal of Radiology, 2012
- FDG-PET/CT in infections: the imaging method of choice?European Journal of Nuclear Medicine and Molecular Imaging, 2010